investordatabase.org

Clal Biotechnology Industries

cbi.co.il Direct investor

Clal Biotechnology Industries is a life sciences investment firm listed on the Tel Aviv Stock Exchange. It holds and manages a portfolio of biotechnology and medical technology companies at various stages of growth.

Clal Biotechnology Industries is an investor headquartered in Tel Aviv, Israel. It invests directly in companies, from seed to growth, in biotechnology, pharmaceuticals, diagnostics and medical devices. 13 portfolio companies, as it reports.

“CBI specializes in identifying and nurturing groundbreaking ventures that develop proprietary solutions to address unmet medical needs with substantial market potential.”

— Clal Biotechnology Industries, own website
Layer
Direct investor
Type
Other
Stage
Seed – Growth
Headquarters
Tel Aviv, Israel
Invests in
Israel, United States, global
Sectors
biotechnology, pharmaceuticals, diagnostics, medical devices, life sciences
Portfolio
13 companies

Team, as Clal Biotechnology Industries publishes it

  • Avi Fischer CEO
  • Arnon Aharon, MD Medical Director
  • Liat Nissan CFO
  • Avi Fischer Chairman of the Board
  • Prof. Gad Keren Board Member
  • Bazil Gamzu Board Member
  • Nufar Malovani Board Member
  • Prof. Gabi Barabash Board Member
  • Tomer Babai Board Member

Names and roles exactly as listed on cbi.co.il. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Clal Biotechnology Industries publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 8589 · added 2026-09-29 · link last verified 2026-09-29 · confidence high

Similar investors

Listed under